These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1031 related articles for article (PubMed ID: 15833864)
1. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864 [TBL] [Abstract][Full Text] [Related]
2. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410 [TBL] [Abstract][Full Text] [Related]
3. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138 [TBL] [Abstract][Full Text] [Related]
5. In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model. Chien LY; Hsiao JK; Hsu SC; Yao M; Lu CW; Liu HM; Chen YC; Yang CS; Huang DM Biomaterials; 2011 Apr; 32(12):3275-84. PubMed ID: 21295344 [TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545 [TBL] [Abstract][Full Text] [Related]
8. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models. Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412 [TBL] [Abstract][Full Text] [Related]
9. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692 [TBL] [Abstract][Full Text] [Related]
10. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256 [TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice. Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Schichor C; Birnbaum T; Etminan N; Schnell O; Grau S; Miebach S; Aboody K; Padovan C; Straube A; Tonn JC; Goldbrunner R Exp Neurol; 2006 Jun; 199(2):301-10. PubMed ID: 16574102 [TBL] [Abstract][Full Text] [Related]
14. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Park SA; Ryu CH; Kim SM; Lim JY; Park SI; Jeong CH; Jun JA; Oh JH; Park SH; Oh W; Jeun SS Int J Oncol; 2011 Jan; 38(1):97-103. PubMed ID: 21109930 [TBL] [Abstract][Full Text] [Related]
15. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267 [TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823 [TBL] [Abstract][Full Text] [Related]
17. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465 [TBL] [Abstract][Full Text] [Related]
18. Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Lamfers M; Idema S; van Milligen F; Schouten T; van der Valk P; Vandertop P; Dirven C; Noske D Cancer Lett; 2009 Feb; 274(1):78-87. PubMed ID: 18842332 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088 [TBL] [Abstract][Full Text] [Related]